Top Genomics Companies

The dramatic decline in genome sequencing costs remains the most influential primary driver of the global genomics market. Continuous improvements in next-generation sequencing platforms, reagent chemistry, automation, and data processing efficiency have reduced both per-sample cost and turnaround time. As sequencing becomes economically viable, adoption expands from elite research centers to routine clinical diagnostics, agricultural genomics, infectious disease surveillance, and large-scale population studies. This surge in accessibility directly increases sequencing volumes and data generation, which in turn fuels sustained demand for sequencing instruments, consumables, cloud-based bioinformatics platforms, and downstream genomic analysis services across global markets.

Industry Overview

According to SkyQuest Technology “Global Genomics Market” By Product & Services (Consumables, Instruments & Systems, Software & Informatics, Services), By Technology, By Application, By Region - Industry Forecast 2025-2032,” Global genomics market is projected to grow at a CAGR of over 12.3% by 2032, on account of urgent need for automating quantified data. The accelerating integration of genomics into precision medicine is a critical factor shaping the genomics market’s growth. As clinicians increasingly rely on genetic profiling to understand disease mechanisms, predict patient response, and select targeted therapies, genomic testing becomes embedded in standard care pathways.

Top 10 Global Genomics Companies

1. Illumina, Inc.

Illumina, Inc. is a global leader in genomics and sequencing technologies, playing a foundational role in advancing genetic research and precision medicine worldwide. Founded in 1998 and headquartered in San Diego, California, the company specializes in next-generation sequencing (NGS) platforms, consumables, and bioinformatics solutions. Illumina’s technologies enable applications across clinical diagnostics, oncology, population genomics, and reproductive health. By continuously reducing sequencing costs and improving data accuracy and throughput, Illumina has significantly expanded access to genomic analysis, positioning itself as a critical enabler of large-scale genomic adoption across research institutions, healthcare systems, and pharmaceutical development globally.

2. Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. is a global leader in life sciences and analytical technologies, with a strong and expanding presence in the global genomics market. Founded in 1956 and headquartered in Waltham, Massachusetts, the company provides end-to-end genomic solutions, including sequencing instruments, PCR and qPCR systems, reagents, consumables, and bioinformatics tools. Thermo Fisher supports applications across clinical diagnostics, translational research, pharmaceutical development, and precision medicine. Its integrated portfolio and continuous investment in genomics innovation enable researchers and healthcare providers to accelerate discovery, improve diagnostic accuracy, and advance personalized treatment strategies worldwide.

3. Agilent Technologies, Inc.

Agilent Technologies, Inc. is a leading global provider of life sciences and diagnostics solutions, with a strong footprint in the global genomics market. Founded in 1999 and headquartered in Santa Clara, California, the company offers advanced genomic tools including microarrays, target enrichment solutions, next-generation sequencing library preparation kits, and cytogenetics platforms. Agilent’s technologies support applications in clinical diagnostics, oncology research, and pharmaceutical development. By delivering high-precision, reliable genomic workflows and analytical systems, Agilent enables laboratories to generate accurate genetic insights, driving adoption of genomics in both research and clinical settings worldwide.

4. BGI Genomics Co. Ltd.

BGI Genomics Co. Ltd. is a prominent global genomics services provider, playing a vital role in large-scale sequencing and precision medicine initiatives worldwide. Founded in 1999 and headquartered in Shenzhen, China, the company specializes in whole-genome sequencing, clinical genomics testing, population genomics, and bioinformatics services. BGI supports applications across healthcare, agriculture, and scientific research, leveraging high-throughput sequencing capabilities and advanced data analysis platforms. Its focus on cost-efficient, large-volume sequencing enables broad access to genomic insights, strengthening disease research, public health programs, and personalized medicine adoption across global markets.

5. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a well-established global player in life science research and clinical diagnostics, with a strong presence in the global genomics market. Founded in 1952 and headquartered in Hercules, California, the company provides critical genomic technologies including digital PCR systems, qPCR instruments, gene expression analysis tools, and molecular biology reagents. Bio-Rad’s solutions support applications in genetic research, oncology, infectious disease testing, and clinical laboratories. By enabling highly accurate nucleic acid quantification and reproducible genomic workflows, Bio-Rad plays a key role in advancing reliable genomic analysis worldwide.

6. Danaher Corporation

Danaher Corporation is a global science and technology innovator with a significant influence on the global genomics market through its life sciences and diagnostics portfolio. Founded in 1969 and headquartered in Washington, D.C., the company operates leading genomics-focused businesses such as Cytiva, Beckman Coulter Life Sciences, and Cepheid. Danaher provides sequencing-adjacent technologies, molecular diagnostics platforms, laboratory automation, and bioanalytical tools. Its continuous investment in genomics-enabled diagnostics and research infrastructure supports faster disease detection, scalable genomic workflows, and the broader adoption of precision medicine worldwide.

7. Eurofins Scientific

Eurofins Scientific is a leading global provider of laboratory testing and genomic services, with a strong and diversified presence in the global genomics market. Founded in 1987 and headquartered in Luxembourg City, Luxembourg, the company offers DNA sequencing, genomic testing, bioinformatics, and data interpretation services across clinical diagnostics, pharmaceuticals, food safety, environmental testing, and forensics. Eurofins’ extensive global laboratory network and service-driven genomics model enable rapid, high-volume testing and reliable genetic analysis, supporting regulatory compliance, research advancement, and precision medicine initiatives worldwide.

8. Roche

Roche is a global leader in pharmaceuticals and diagnostics, with a significant and growing role in the global genomics market. Founded in 1896 and headquartered in Basel, Switzerland, the company integrates genomics into molecular diagnostics, companion diagnostics, and precision oncology solutions. Through its diagnostics division, Roche provides genomic testing platforms, next-generation sequencing–based assays, and decision-support tools that enable targeted therapy selection. By aligning genomic insights with drug development and clinical care, Roche strengthens personalized medicine adoption and drives improved patient outcomes across healthcare systems worldwide.

9. QIAGEN N.V.

QIAGEN N.V. is a leading global provider of sample preparation and molecular testing technologies, playing a critical role in the global genomics market. Founded in 1984 and headquartered in Venlo, the Netherlands, the company specializes in nucleic acid extraction, purification, PCR-based assays, and bioinformatics solutions. QIAGEN’s technologies serve clinical diagnostics, life science research, and pharmaceutical applications, enabling reliable genomic workflows from sample to insight. By ensuring high-quality genetic material and accurate data interpretation, QIAGEN supports the scalable adoption of genomics in precision medicine, infectious disease testing, and translational research worldwide.

10. Pacific Biosciences

Pacific Biosciences of California, Inc. (PacBio) is a leading innovator in long-read sequencing technologies, with a focused role in the global genomics market. Founded in 2004 and headquartered in Menlo Park, California, the company develops advanced single-molecule, real-time (SMRT) sequencing platforms. PacBio’s technologies enable highly accurate whole-genome sequencing, structural variant detection, epigenetic analysis, and de novo genome assembly. By addressing complex genomic regions that short-read methods often miss, PacBio supports advanced research, clinical genomics, and precision medicine applications worldwide.

Other Leading Global Genomics Companies

• Quest Diagnostics Incorporated
• Myriad Genetics, Inc.
• Oxford Nanopore Technologies plc
• 23andMe Holding Co.
• 10x Genomics, Inc.
• Helix
• Color Genomics, Inc.
• Eppendorf AG
• Eurofins USA Genomic Services
• GE HealthCare

Conclusion

In conclusion, the global genomics market is undergoing rapid and sustained expansion, driven by falling sequencing costs and the deepening integration of genomics into precision medicine. As genomic technologies become more accessible, their adoption is accelerating across clinical diagnostics, drug discovery, population health, and agricultural applications. Strong growth forecasts underscore rising investments in sequencing platforms, bioinformatics, and genomic services. Leading players such as Illumina, Thermo Fisher Scientific, Roche, and BGI continue to shape the competitive landscape through innovation and scale. Together, technological advancement, clinical relevance, and expanding use cases position genomics as a cornerstone of next-generation healthcare and life sciences.